Search results
18 cze 2019 · Twenty years ago, 18-year-old Jesse Gelsinger died after taking part in a clinical trial for gene therapy at the University of Pennsylvania. The tragedy sent shock waves through Philadelphia’s biotech industry and across the medial world.
4 cze 2019 · On September 14, 1990, at the age of 4, DeSilva became the first gene-therapy patient when she was implanted with corrected genes to address her form of severe combined immunodeficiency, often called bubble boy disease.
21 maj 2021 · Twenty-two years ago, one of scientists' first attempts at gene therapy ended in tragedy when a young man died. The story of Jesse Gelsinger, who had a rare liver disorder, became a textbook example of irresponsible medical research.
11 paź 1999 · J esse Gelsinger, 18, had good reasons not to sign up for experimental gene therapy. Though the Tucson, Ariz., teen was born with a rare genetic disorder that partly disabled his liver, his...
It has been 9 years since Mr. Jesse Gelsinger died from complications of vector administration in a liver gene therapy trial of research subjects with a deficiency of ornithine transcarbamylase (OTCD).
1 wrz 2009 · Philadelphia—Ten years ago this month the promise of using normal genes to cure hereditary defects crashed and burned, as Jesse Gelsinger, an 18-year-old from Tucson, Ariz., succumbed to...
18 maj 2021 · Twenty-two years ago, one of scientists' first attempts at gene therapy ended in tragedy when a young man died. The story of Jesse Gelsinger, who had a rare liver disorder, became a textbook example of irresponsible medical research.
